Blog

November 30, 2015

DMG TrialWire appointed for Crohn’s disease rapid patient recruitment

DMG has been appointed for patient recruitment support for a new global Study on Crohn’s disease.

DMG’s rapid patient recruitment product TrialWire leverages the reach of news media to inform target patients about a Study. The news features can include the Study website or the Clinic contacts for more information and ultimately screening.Online search

TrialWire delivers “earned media” or news or editorial media produced by health journalists and bloggers.

Health is big news because everyone wants to be healthy and new research and discoveries are always top news items for journalists and editors.

With 1 in 20 Google searches now about health and self-diagnosis and cures, being in the news media in organic search is vital for a successful Study.

DMG has been delivering clinical trial patient recruitment solutions via the news media since 2001 working with some of the world’s largest pharma. biotech and CROs.

 

 

Clinical Trials , , , , ,
About DMG